Skip to content

The FASEB Journal

ISSN 0892-6638

39 papers in the library · 156 citations · publishing 1997-2025

Papers

Sort Most recent Most cited

Pharmacokinetic and pharmacodynamic interactions of indolealkylamine drugs of abuse

The FASEB Journal April 1, 2012 Ai-Ming Yu

Indolealkylamine (IAA) drugs are a major class of serotonin analogs that have high impact as substances of abuse. Among them, 5‐methoxy‐ N,N ‐dimethyltryptamine (5‐MeO‐DMT) was placed into Schedule I controlled substance status in the United States as of January 19, 2011, which is often co‐abused with harmaline. IAA drugs acts mainly on the serotonin neurotransmission system. Overdose of one...

Interaction of ibogaine with human a3b4 nicotinic receptors in different conformational states

The FASEB Journal April 1, 2012 Ilana Emert, Katarzyna M Targowska-Duda, Dominik Feuerbach et al.

The interaction of ibogaine and phencyclidine (PCP) with human (h) α3β4 nicotinic acetylcholine receptors (AChRs) in different conformational states was determined using radioligand binding assays, Ca 2+ influx detections, thermodynamic and kinetic measurements. The results show that ibogaine inhibits (±)‐epibatidine‐induced Ca 2+ influx in hα3β4 AChRs with ~9‐fold higher potency than PCP, [ 3...

Chronic LSD administration produces changes in mPFC gene and protein expression relevant to schizophrenia, as determined by RNA‐Seq and DIGE

The FASEB Journal April 1, 2012 David Martin, David E. Nichols, Charles D. Nichols

The objective of this work is to characterize genetic and proteomic changes in a novel rat model of schizophrenia. Three‐month treatment with low doses of the hallucinogenic drug, LSD, induces a range of abnormal behaviors including social deficits, hyperactivity, and anhedonia. These behavioral changes persist in the absence of drug , and likely result from neuroadaptive changes in the medial...

Antidepressant‐like effect of AMPA and ketamine combination in male Wistar ‐Kyoto rats

The FASEB Journal April 1, 2012 Luli R Akinfiresoye, D. M. Lovinger, Y. Tizabi

Studies have shown that therapeutics that act on the glutamatergic system could provide a novel mechanistic approach for the treatment of depression. We previously reported that ketamine, an NMDA antagonist, has a rapid and lasting antidepressant effect both acutely and chronically on depressive‐like behavior in Wistar‐Kyoto (WKY) rats ( Soc Neurosci Abst 2008) . Other studies had suggested...

Neuropharmacology of 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) and its stereoisomers: a combined positron emission tomography and functional magnetic resonance imaging study in rhesus monkeys

The FASEB Journal April 1, 2011 Kevin S. Murnane, Leonard L. Howell

3,4-methylenedioxymethamphetamine (MDMA) is a substituted amphetamine derivative that is widely abused as the street drug “ecstasy”. Despite its high abuse liability, the neuropharmacology of MDMA remains poorly understood. In the present study, functional magnetic resonance imaging (fMRI) was used in fully conscious rhesus monkeys to characterize the neuroactivational effects of MDMA and its...

Functional selectivity at the serotonin 2A receptor: differential signaling by serotonin and dimethylated tryptamines

The FASEB Journal April 1, 2010 Cullen L. Schmid, Laura Bohn

Serotonin and the hallucinogenic metabolites of tryptamines, dimethylated tryptamines, activate the serotonin 2A receptor (5‐HT2AR), which is implicated in numerous mental health disorders. We have previously demonstrated that the 5‐HT2AR is differentially regulated by βarrestin2 (βarr2) depending upon the agonist; here we utilized βarr2 knockout mice to compare signaling profiles in vivo, by...

Morphological adaptations in the brain motive circuit induced by 3,4‐methylenedioxymethamphetamine (MDMA; ecstasy)

The FASEB Journal April 1, 2010 Kevin T. Ball

MDMA is a widely used amphetamine derivative that increases dopamine and serotonin transmission via its interaction with monoamine transporters. Compared to other psychostimulants, little is known about the long‐term neurobehavioral effects of MDMA. We conducted a series of studies aimed at elucidating the effects of MDMA administration on behavior, limbic cortico‐striatal neuronal structure,...

Current Drug Scheduling Reviews Reported by DEA

The FASEB Journal April 1, 2009 Sandy Ghozland, Srihari R. Tella, Michelle D. Walker et al.

Pursuant to the Controlled Substances Act (CSA), DEA collects and reviews scientific, medical and other data for substances with abuse potential for possible placement under the CSA. The administrative process for scheduling is ongoing for indiplon, carisoprodol, dextromethorphan, salvinorin A and several petitions requesting a change in the control status of nabilone, methylphenidate product,...

Interaction of ibogaine analogs with the nicotinic acetylcholine receptor

The FASEB Journal April 1, 2008 Krzysztof Jozwiak, Ruin Moaddel, Irving W. Wainer et al. 2 citations

PURPOSE: Characterization of the binding sites for ibogaine analogs on the nicotinic acetylcholine receptor (AChR) in the resting and desensitized states. METHODS: [ 3 H]18‐methoxycoronaridine ([ 3 H]18‐MC) Scatchard‐plots using Torpedo AChR membranes, [ 3 H]TCP (a well characterized noncompetitive antagonist) competition binding experiments and Schild‐type analysis, analog‐induced binding...

N,N ‐dialkyltryptamines inhibit plasma membrane and vesicular serotonin transport

The FASEB Journal March 1, 2008 Nicholas V. Cozzi, Anupama Gopalakrishnan, Lyndsey L. Anderson et al.

The plant hallucinogen N,N ‐dimethyltryptamine (DMT) has been used for religious and other purposes for many centuries. Over the past few decades, DMT has been reported in human brain, and pharmacological studies have shown that DMT binds to monoamine receptors. Recently, several N,N ‐dialkyltryptamines were reported to modify monoamine uptake and release in rat brain synaptosomes, indicating...

Discriminative stimulus effects of hallucinogens and psychostimulants in S(+)‐MDMA, and R(−)‐MDMA trained mice

The FASEB Journal March 1, 2008 Kevin Sean Murnane, Leonard L. Howell, William E Fantegrossi

3,4‐Methylenedioxymethamphetamine (MDMA) is an amphetamine derivative with increasingly widespread abuse. MDMA has been difficult to classify as a stimulant or hallucinogen because it shares effects with both drug classes. Furthermore, racemic MDMA is composed of two isomers that vary in terms of behavioral effects rather than simple potency differences. Specifically, the R(−) isomer of MDMA...

Effects of the N343A mutation in TM6 of the human serotonin 5‐HT2A Receptor

The FASEB Journal March 1, 2006 M. Braden, James J. Chambers, David E. Nichols

The human serotonin 2A receptor (h5‐HT 2A R) plays an essential role in cognition, and is the principal target for serotonergic hallucinogens as well as atypical antipsychotics. Utilizing our in silico ‐activated h5‐HT 2A R homology model, an interaction was predicted between Asn343(6.55) in TM6 and the carbonyl of LSD. Virtual docking simulations of a new class of 5‐HT2 agonists, substituted N...

Analysis of Ecstasy (MDMA)‐induced transcriptional responses in the rat cortex

The FASEB Journal December 1, 2002 Bruce Ladenheim, Michael Mccoy, Jean Lud Cadet et al. 34 citations

ABSTRACT 3,4‐Methylenedioxymethamphetamine (MDMA, ecstasy) is a popular drug of abuse. MDMA is pharmacologically classified as an entactogen because of its affinities to classical hallucinogens and stimulants. Oral ingestion of a single dose of the drug is associated with euphoria, elevated self‐confidence, and heightened sensory awareness in humans. Evidence for neurotoxicity in the human...

The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells

The FASEB Journal February 1, 1997 Rabi Simantov, M Tauber 89 citations

The widely abused amphetamine analog 3,4‐methylenecdioxymethamphetamine (MDMA, also called “ecstasy”) induces hallucination and psychostimulation, as well as long‐term neuropsychiatric behaviors such as panic and psychosis. In rodents and monkeys, MDMA is cytotoxic to serotonergic neurons, but this is less clear with humans. Herein, MDMA was cytotoxic to human serotonergic JAR cells; it altered...